TARSUS PHARMACEUTICALS, INC. (TARS) Operating cash flow 2019–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$12.5MFY2025 · since FY2019: -$3.7M → -$12.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.5M | +85.0% |
| FY2024 | -$83.0M | +29.3% |
| FY2023 | -$117.5M | -139.6% |
| FY2022 | -$49.0M | -1408.2% |
| FY2021 | $3.7M | +117.7% |
| FY2020 | -$21.1M | -475.5% |
| FY2019 | -$3.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TARS financial trends
TARS RevenueTARS Net incomeTARS Net marginTARS Gross profitTARS Gross marginTARS Operating incomeTARS Operating marginTARS Free cash flowTARS Capital expendituresTARS Return on equityTARS Stock buybacksTARS Dividends paidTARS Total assetsTARS Total liabilitiesTARS Shareholders’ equityTARS overview →